"Addressing even one crore patients translates to a Rs 3,0004,000 crore opportunity," he says, "but the market will only expand meaningfully at lower price points, especially beyond metros." He expects the GLP-1 category to surpass Rs 2,000 crore within a year, led by generics driving down entry barriers
Overall, when administering GLP-1RA plus SGLT2i combination therapy, it is important to adopt an individualized approach to therapy taking into account individual preferences, costs and coverage, AE profile, consideration of kidney function and glucose-lowering efficacy, desire for weight loss, and comorbidities such as frailty [6, 22, 24]
Over time, patients notice improved glucose readings, a healthier body composition, and reduced risk of diabetes-related complications
It exists in virtually every cell, neutralizing reactive oxygen species that would otherwise damage DNA, proteins, and cell membranes